Skip to main content
. 2022 Feb 15;12:834068. doi: 10.3389/fonc.2022.834068

Table 3.

Cross-sectional studies reporting health-reported quality of life in elderly HNSCC cohorts. .

Author Year n Location Handling of age H&N subsite Treatment Instrument Study design Global QoL findings Other findings
Alicikus et al. (81) 2008 110 Turkey ≤60 vs >60 years LC, 58%
NPC, 18%
OC/OPC, 14%
Other, 6%
All received RT/CRT
RT, 42%
CRT, 13%
aRT, 43%
aCRT, 2%
QLQ-C30
QLQ-H&N35
Cross-sectional (median 29m, range 4-155m) Global QoL not SS (69 v 70) PF, RF, SF, CF not different (EF not reported); younger patients reported more problems with teeth (44 vs 18) and opening mouth (30 v 15);
Baxi et al. (82) 2018 185 USA <65 vs ≥65 years All HPV+ OPC All received RT/CRT definitive, 86%
Adjuvant, 14%
EQ-5D, QLQ-H&N35 Cross-sectional (>12 months from RT) Global QoL (EQ-5D VAS) similar (86 vs 81; p=0.20) Older patients worse mobility (EQ-5D), remainder of EQ-5D similar; worse social eating (ED 11.1, p<0.0001) and coughing (ED 11.7, p=0.009)
Bonzanini et al. (83) 2020 90 Brazil <62 vs ≥62 years OCC/OPC, 60%
LC, 34%
HPC, 6%
All received RT
Sx + aRT, 19%
Sx + aCRT, 40%
RT, 7%
CRT, 34%
UW-QoL Cross-sectional Mean scores 60 vs 74; age SS on MVA Younger patients reported worse pain (64 v 81), appearance (70 vs 81), swallowing (56 v 75), chewing (55 v 70), shoulder problems (56 v 84), saliva (43 v 59)
Bozec et al. (84) 2020 64 France <80 vs >80 years (inc ≥70 years) All OC/OPC All free flap reconstruction
Sx alone, 22%
aRT, 61%
aCRT, 17%
QLQ-C30
QLQ-H&N35
QLQ-ELD14
Cross-sectional (>12 months after Sx) Global QoL not SS (value NR) Mobility score on QLQ-ELD14 favouring younger 16.7 vs 22.0, p=0.004); remainder not SS
Dwivedi et al. (85) 2012 55 United Kingdom <60 vs ≥60 years OCC and OPC All Primary Sx
Sx alone, 11%
Sx + aRT, 49%
Sx + aCRT, 40%
UW-QoL Cross-sectional Mean composite score of 12 domains used - younger worse (70 vs 80, p=0.01);
Infante-Cossio et al. (86) 2009 128 Spain <65 vs >65 years OCC, 55%
OPC, 45%
NR QLQ-C30
QLQ-H&N35
Collected at time of diagnosis Age not SS for global QoL (median 83.3 vs 83.3, p=NS) PF, CF, fatigue, pain worse in older patients (all p<0.05, based on median scores, all scores <10 except for fatigue)
Laraway (87) 2012 638 United Kingdom <55 vs 55-64 vs 65-74 vs ≥75 years All OCC Sx, 99%
Sx + aRT/CRT, 32%
CRT/RT, 1%
UW-QoL Cross-sectional; “closest to 1 year after surgery” Patients ≥65 reported better overall QoL (proportion reporting good or better, p<0.001) Many domains favored the older age groups in both the physical and socioemotional domains
Morimata et al. (88) 2013 100 Japan 65 vs >65 years Maxillectomy, 50% Mandibulectomy, 50% Maxillectomy, 54% aRT
Mandibulectomy, 32% aRT
UW-QoL (v4.0) Cross-sectional Age not SS for global QoL in either maxillectomy (p=0.80) or mandibulectomy population (p=0.54) Maxillectomy:
younger patients more anxious (p=0.01)
Mandibulectomy:
younger patients better swallowing (p=0.01), saliva (p=0.04) and mood (p=0.03)
Pierre et al. (89) 2014 80 France <70 vs >70 years OCC, 46%
OPC, 54%
All Surgical patients with microvascular reconstruction
aRT, 69%
naRT, 11%
QLQ-C30
QLQ-H&N35
Cross-sectional Age NS for global QoL Age NS for all items/scales
Pourel et al. (90) 2002 113 France ≤62 vs >62 years All OPC Sx + RT, 23%
BT + RT, 43%
RT, 33%
QLQ-C30
QLQ-H&N35
Cross-sectional (≥2y post RT) Global QoL not SS (66 vs 64, p=0.70) Other functional scales, fatigue did not differ; pain worse in younger (32 vs 21, p=0.03)
Silvieri et al. (91) 2011 289 Portugal 40-60 vs ≥65 years Younger:
LC, 31%
OC, 16%
OPC, 11%
Older:
LC, 30%
OC, 13%
OPC, 3%
Younger:
Sx, 71%
RT, 8%
CT, 10%
CRT, 11%
Older:
Sx, 79%
RT, 14%
CT, 2%
CRT, 5%
QLQ-C30
QLQ-H&N35
Cross-sectional (3-9m post Rx) Global QoL similar across all groups when analyzed by gender Some small-sized differences reported (i.e. younger males less constipation, worse financial difficulties; older females worse PF (medium-sized), remainder differences small-sized
Few significant differences in QLQ-H&N35 in young vs older males, except for higher sexuality problems in older males (26 vs 39); for females, only speech problems were clinically significant and borderline SS in younger (35 v 18)
Verma et al. (92) 2019 58 USA <65 vs ≥65 years HNSCC, further details NR Definitive RT/CRT, 50%
Sx + aRT/naRT, 50%
CT, 72%
QLQ-C30, Dental health, shoulder function Cross-sectional Global QoL NS Older patients’ better RF (95 vs 76), EF (89 vs 79) and lower pain (4 vs 29), insomnia (8 vs 36) an financial problems (8 vs 38)
Wells et al. (93) 2015 289 United Kingdom <45 vs 45-54 vs 55-64 vs 65-74 vs ≥75 years OCC, 34%
OPC, 20%
LC, 33%
Other, 13%
Sx alone, 26%
Sx + aRT, 11%
Sx + CT, 1%
Sx + aCRT, 23%
RT, 17%
CRT, 18%
QLACS Cross-sectional (≥3m but <5y post Rx) Generic QoL:
younger not SS (83.8 vs 82.9 vs 79.8 vs 70.0 vs 73.3, p=0.118); higher score = worse)
Cancer-specific QoL:
younger worse (43.8 vs 46.8 vs 40.5 vs 34.1 vs 31.5, p<0.001) (higher score = worse)
Williamson et al. (94) 2011 41 USA <70 vs ≥ 70 years All LC Sx + aRT/CRT, 27%
RT, 63%
CRT, 10%
UW-QoL Cross-sectional Age NS for overall QoL (even when ≥75 was compared) Age NS for other items/scales
Woodard et al. (95) 2007 33 USA ≤65 vs >65 years All LC/HPC Laryngectomy, 100%
± adj and previous RT/CRT
HNCI Cross-sectional (mean 37m) Older SS better global QoL 75 vs 54) Older SS better in all 4 domains (speech, eating, social disruption, aesthetic)

aRT/CRT, adjuvant radiotherapy/chemoradiotherapy; CF, cognitive functioning CRT, chemoradiotherapy; ED, estimated difference; EF, emotional functioning; EQ-5D, EuroQoL 5-Dimension; H&N, head and neck; HNCI, Head Neck Cancer Inventory; HPC, hypopharyngeal cancer; LC, laryngeal cancer; MVA, multi- variate/variable analysis; NR, not recorded; OC, oral cavity; OPC, oropharyngeal cancer; QLACS, Quality of Life of Adult Cancer Survivors; QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; QLQ-ELD14, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Elderly Cancer Patients module; QLQ-H&N35, European Organization for Research and Treatment of Cancer Quality of Life-Head and Neck module; QoL, Quality of life; PF, physical functioning; RF, Role functioning; RT, radiotherapy; SF, Social functioning; SS, statistically significant; Sx, surgery; UW-QoL, University of Washington Quality of Life instrument.